FR2836377A1 - Process for preparing a topical composition by stirring a mixture of essential oils and arnica tincture, for the treatment of herpes and acne - Google Patents

Process for preparing a topical composition by stirring a mixture of essential oils and arnica tincture, for the treatment of herpes and acne Download PDF

Info

Publication number
FR2836377A1
FR2836377A1 FR0200788A FR0200788A FR2836377A1 FR 2836377 A1 FR2836377 A1 FR 2836377A1 FR 0200788 A FR0200788 A FR 0200788A FR 0200788 A FR0200788 A FR 0200788A FR 2836377 A1 FR2836377 A1 FR 2836377A1
Authority
FR
Grant status
Application
Patent type
Prior art keywords
action
chosen
stirring
essential oil
hour
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR0200788A
Other languages
French (fr)
Other versions
FR2836377B1 (en )
Inventor
Ammar Taleb
Edgard Skrzypczak
Original Assignee
Ammar Taleb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/532Agastache, e.g. giant hyssop
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/001Preparations for care of the lips

Abstract

A process for preparing a topical composition of essential oils for the treatment of herpes and acne. A process for preparing a topical composition of essential oils for the treatment of herpes and acne comprises the following: (a) mixing together essential oils selected from marjoram, Chinese geranium, noble laurel, lavender, hyssop, wild mint, palm, chamomile, lemon eucalyptus, Spanish oregano, tea tree, and sunflower, with an equal volume of vegetable tincture containing arnica and stirring the mixture at 999 rpm in a glass vessel for one hour, then decanting the mixture after 24 hours; (b) adding an equal volume of vegetable tincture and stirring at 498 rpm for 1 hour and decanting after 48 hours; (c) incorporating vegetable tincture (quantity not stated) into the mixture from b) and stirring at 248 rpm for 1 hour, then decanting after one week; and (d) adding vegetable oil (quantity not stated) to the mixture from c) and stirring for one hour then decanting 15 days.

Description

<Desc/Clms Page number 1> <Desc / CRUD Page number 1>

La présente invention consiste en un mode opératoire spécifique pour énergiser et spécifier l'action des huiles essentielles en mettant en évidence leurs propriétés énergétiques qui leur confèrent une plus grande efficacité à de faibles concentrations sur le chimisme physiologique cutané dans une préparation pour application topique contre l'acné et l'herpès labial ou solaire, tout en réduisant leur effet secondaire majeur qui est l'action vésicante. The present invention is a specific procedure to energize and specify the action of essential oils highlighting their energy properties that make them more effective at low concentrations on the skin physiological chemistry in preparation for topical application against the acne and herpes labialis or solar, while reducing their major side effect is the blistering action.

Les huiles essentielles, non limitatives, entrant dans la préparation fabriquée selon le protocole pour illustrer l'invention, sont : * l'huile essentielle de marjolaine à coquilles choisie pour son action régulatrice hormonale * l'huile essentielle de géranium de chine choisie pour son action antibiotique * l'huile essentielle de laurier noble choisie pour son action cicatrisante * l'huile essentielle de lavande officinale choisie pour son action anti-inflammatoire * l'huile essentielle d'hysope officinale choisie pour son action anti-coagulante * l'huile essentielle de menthe sauvage choisie pour son action anesthésiante * l'huile essentielle de palmarosa choisie pour son action antibiotique spécifique 'l'huile essentielle de camomille romaine choisie pour son action cicatrisante * l'huile essentielle d'eucalyptus citronné choisie pour son action anti-thermique * l'huile essentielle d'origan d'Espagne choisie pour son action anti-virale 'l'huile essentielle de tea tree pour s Essential oils, not limiting, used in the preparation produced according to the protocol to illustrate the invention, are: * essential oil marjoram shells chosen for its hormonal regulatory action * essential oil of geranium china chosen for its essential antibiotic action * oil laurel chosen for its healing action * the essential oil of lavender chosen for its anti-inflammatory action * essential oil officinale hyssop chosen for its anti-coagulant action oil * wild mint essential chosen for its anesthetic action * essential oil palmarosa chosen for its specific antibiotic action 'essential oil of Roman chamomile chosen for its healing action * the lemon eucalyptus essential oil chosen for its action anti- * thermal essential oil of oregano Spain selected for its anti-viral action 'essential oil of tea tree for s on action anti-virale spécifique La teinture végétale, non limitative, entrant dans la préparation fabriquée selon le protocole pour illustrer l'invention est l'arnica choisie pour ses propriétés anti-oedémateuses L'huile végétale, non limitative, choisie pour son action de tolérance cutanée, entrant dans la préparation fabriquée selon le protocole pour illustrer l'invention est l'huile végétale bio de tournesol one specific anti-viral action Natural dyes, non-limiting, used in the preparation manufactured according to the protocol to illustrate the invention arnica is chosen for its anti-edematous properties The vegetable oil, non-limiting, selected for its action skin tolerance, used in the preparation manufactured according to the protocol to illustrate the invention is vegetable oil sunflower bio

<Desc/Clms Page number 2> <Desc / CRUD Page number 2>

Ce protocole de fabrication pour illustrer l'invention est le suivant : 1 ) La totalité des huiles essentielles est mélangée avec un volume égal de teinture végétale ; This manufacturing protocol to illustrate the invention is as follows: 1) All of the essential oils is mixed with an equal volume of vegetable dye; une émulsion se crée, mettant en état micillaire les molécules aromathérapiques. an emulsion is created, using the state micillaire aromatherapy molecules.

2 ) Un mélange centrifugée en récipient verre est réalisé avec agitation à une cadence de 999 fois minute pendant 1 heure, suivi d'une décantation de 24 heures ; 2) A mixture centrifuged glass container is carried out with stirring at a rate of 999 times minute for 1 hour, followed by decantation of 24 hours; cette dynamisation provoque une stimulation électrique des molécules des huiles essentielles par frottement sur paroi verre, pendant le temps défini, mettant en évidence et en application l'énergétique des huiles essentielles. this causes dynamic electrical stimulation molecules essential oils by friction on glass wall, for the time set, highlighting and energy application of essential oils.

3 ) Au volume de liquide obtenue est ajouté un volume égal de teinture végétale, suit un mélange centrifugée avec agitation à une cadence de 498 fois minute pendant une heure suivi décantation de 48 heures. 3) the volume of liquid obtained was added an equal volume of vegetable dye follows a mixture centrifuged with stirring at a rate of 498 times minute for one hour followed 48 hours settling.

Cette dynamisation provoque une amplification de la première stimulation électrique des molécules des huiles essentielles par frottement sur paroi verre, pendant le temps défini, augmentant l'énergétique des huiles essentielles. This revitalization leads to amplification of the first electrical stimulation molecules essential oils by friction on glass wall, for the set time, increasing the energy of essential oils.

4 ) 1'intégralité de ou des teintures végétales sont alors incorporées, suit un mélange centrifugée avec agitation à une cadence de 248 fois minute pendant une heure, suivi d'une décantation d'une semaine. 4) 1'intégralité of or vegetable dyes are then incorporated, follows a centrifuged mixture with stirring at a rate of 248 times minute for one hour, followed by decantation of a week.

Cette dynamisation provoque une stabilisation de la deuxième stimulation électrique des molécules des huiles essentielles par frottement sur paroi verre, pendant le temps défini, stabilisant l'énergétique des huiles essentielles. This causes a dynamic stabilization of the second electrical stimulation molecules essential oils by friction on glass wall, for the time set, stabilizer essential oils energy.

5 ) La ou les huiles végétales en totalité sont incorporées au mélange teinture (s) végétale (s) huiles essentielles, en une seule fois, suit un dernier mélange centrifugé avec agitation à une cadence de 124 fois minute pendant 1 heure puis l'ensemble est mis en décantation une dernière fois pendant une période de 15 jours. 5) or vegetable oils are incorporated in wholly dye mixture (s) plant (s) essential oils, at one time, following a last centrifuged mixture with stirring at a rate of 124 times minute for 1 hour then all is set settling one last time for a period of 15 days.

Cette dynamisation provoque une fixation de la troisième stimulation électrique des molécules des huiles essentielles par frottement sur paroi verre, pendant le temps défini, fixant définitivement l'énergétique des huiles essentielles. This boosting causes a fixation of the third electrical stimulation molecules essential oils by friction on glass wall, for the time set, permanently fixing essential oils energy.

Figure img00020001

6 ) Au bout de la période définie, la solution finale constituée d'huiles essentielles énergisées grâce aux phases opératoires citées ci dessus, est prête à l'emploi. 6) At the end of the defined period, the final solution consisting of essential oils energized through the process steps mentioned above, is ready for use.

Claims (1)

  1. 1. Procédé d'obtention d'une composition topique antiacnéique ou contre l'herpès labial ou solaire à base d'huiles essentielles, efficace à faible concentration caractérisé en ce que : a) On mélange une huile essentielle, choisie parmi : * l'huile essentielle de marjolaine à coquilles choisie pour son action régulatrice hormonale 1. A method of obtaining an anti-acne topical composition or against herpes labialis or solar based on essential oils, low effective concentration, characterized in that: a) mixing an essential oil selected from: * the essential oil of marjoram shells chosen for its hormonal regulatory action
    Figure img00030001
    * l'huile essentielle de géranium de Chine choisie pour son action antibiotique 'l'huile essentielle de laurier noble choisie pour son action cicatrisante 'l'huile essentielle de lavande officinale choisie pour son action antiinflammatoire l'huile essentielle d'hysope officinale choisie pour son action anti-coagulante l'huile essentielle de menthe sauvage choisie pour son action anesthésiante l'huile essentielle de palmarosa choisie pour son action antibiotique spécifique l'huile essentielle de camomille romaine choisie pour son action cicatrisante l'huile essentielle d'eucalyptus citronné choisie pour son action anti-thermique l'huile'essentielle d'origan'd'Espagne choisie pour son action anti-virale l'huile essentielle de tea tree pour son action anti-virale spécifique l'huile végétale bio de tournesol pour son action de tolérance cutanée, de préférence l'huile végétale bio de tournesol avec un volume égal de teinture végétale consistant en de l'arnica choisie pour se * Essential oil of geranium China chosen for its antibiotic action 'essential oil of noble laurel chosen for its healing action' essential oil of lavender chosen for its anti-inflammatory action essential oil hyssop officinalis chosen its anticoagulant action essential oil of wild mint chosen for its anesthetic action essential oil palmarosa chosen for its specific antibiotic action essential oil Roman chamomile chosen for its healing action the essential oil of lemon eucalyptus selected for its anti-thermal action of the huile'essentielle origan'd'Espagne chosen for its anti-viral action essential tea tree oil for its specific anti-viral action vegetable oil sunflower organic its action skin tolerance, preferably vegetable oil sunflower bio with an equal volume of vegetable dye consisting of arnica chosen to s propriétés anti oedenateuses, par centrifugation dans un récipient en verre avec agitation à une cadence de s anti oedenateuses properties, by centrifugation in a glass container with stirring at a rate of
    999 fois par minute pendant 1 heure, puis on décante pendant 24 heures. 999 times per minute for 1 hour, then decanted for 24 hours. b) On ajoute au volume de liquide obtenu en a) un volume égal de teinture végétale, on centrifuge avec agitation à une cadence de 498 fois/minutes pendant 1 heure, puis on décante pendant 48 heures. b) was added to the volume of liquid obtained in a) an equal volume of vegetable dye, centrifuged with stirring at a rate of 498 times / minute for 1 hour, then decanted for 48 hours. c) On incorpore au mélange obtenu en b) de la teinture végétale, qu'on centrifuge avec agitation à une cadence de 248 fois par minute pendant 1 heure, suivit d'une décantation pendant une semaine. c) incorporated into the mixture obtained in b) of the vegetable dye, which centrifugal with stirring at a rate of 248 times per minute for 1 hour, followed by decantation for a week. d) Et on ajoute au mélange obtenu en c) de l'huile végétale qu'on centrifuge avec agitation à une cadence de 124 fois par minute pendant 1 heure, suivit d'une décantation pendant 15 jours, et on obtient ainsi une solution constituée d'huiles essentielles énergisées, prête à l'emploi. d) and added to the mixture obtained in c) vegetable oil that centrifugal with stirring at a rate of 124 times per minute for 1 hour, followed by decantation for 15 days, thus obtaining a solution essential oils energized, ready to use.
FR0200788A 2002-02-26 2002-02-26 operative mode for the production of essential oils synergies against acne and solar herpes Expired - Fee Related FR2836377B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0200788A FR2836377B1 (en) 2002-02-26 2002-02-26 operative mode for the production of essential oils synergies against acne and solar herpes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200788A FR2836377B1 (en) 2002-02-26 2002-02-26 operative mode for the production of essential oils synergies against acne and solar herpes

Publications (2)

Publication Number Publication Date
FR2836377A1 true true FR2836377A1 (en) 2003-08-29
FR2836377B1 FR2836377B1 (en) 2005-02-11

Family

ID=27675987

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0200788A Expired - Fee Related FR2836377B1 (en) 2002-02-26 2002-02-26 operative mode for the production of essential oils synergies against acne and solar herpes

Country Status (1)

Country Link
FR (1) FR2836377B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102274420A (en) * 2011-08-15 2011-12-14 成都绿迪科技有限公司 Chinese medicine for treating acne composition
CN101229288B (en) 2008-01-18 2012-03-21 北京中科雍和医药技术有限公司 Compound essential oil for grease clearing and acne dispelling

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2565824A1 (en) * 1984-06-15 1985-12-20 Laumon Jean Composition for dispersion in the atmosphere, counteracting the craving to smoke tobacco
WO1992006700A1 (en) * 1990-10-22 1992-04-30 Mankovitz Roy J Topical preparation and method for suppression of skin eruptions caused by herpes simplex virus
FR2689011A1 (en) * 1992-03-25 1993-10-01 Skrzypczak Edgard Topical cosmetic for treating lesions of lips - contg. aroma:therapy oils, vegetable dye and vegetable oil
FR2715848A1 (en) * 1994-02-07 1995-08-11 Skrzypczak Edgard Topical emulsion for acne, eczema and allergies
FR2743722A1 (en) * 1996-01-23 1997-07-25 Puyravaud Michelle Clay mask containing essential oils to treat acne and open pores
EP0870507A1 (en) * 1997-04-02 1998-10-14 Farmo-Nat Ltd. Synergistic herbal extracts
FR2783715A1 (en) * 1998-09-29 2000-03-31 Rinrone Ets Composition for external use for treating wounds and burns, contains mixture of plant tinctures and essential oils and a local anesthetic having an immediate short term action

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2565824A1 (en) * 1984-06-15 1985-12-20 Laumon Jean Composition for dispersion in the atmosphere, counteracting the craving to smoke tobacco
WO1992006700A1 (en) * 1990-10-22 1992-04-30 Mankovitz Roy J Topical preparation and method for suppression of skin eruptions caused by herpes simplex virus
FR2689011A1 (en) * 1992-03-25 1993-10-01 Skrzypczak Edgard Topical cosmetic for treating lesions of lips - contg. aroma:therapy oils, vegetable dye and vegetable oil
FR2715848A1 (en) * 1994-02-07 1995-08-11 Skrzypczak Edgard Topical emulsion for acne, eczema and allergies
FR2743722A1 (en) * 1996-01-23 1997-07-25 Puyravaud Michelle Clay mask containing essential oils to treat acne and open pores
EP0870507A1 (en) * 1997-04-02 1998-10-14 Farmo-Nat Ltd. Synergistic herbal extracts
FR2783715A1 (en) * 1998-09-29 2000-03-31 Rinrone Ets Composition for external use for treating wounds and burns, contains mixture of plant tinctures and essential oils and a local anesthetic having an immediate short term action

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199303, Derwent World Patents Index; Class D21, AN 1993-024974, XP002268120 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101229288B (en) 2008-01-18 2012-03-21 北京中科雍和医药技术有限公司 Compound essential oil for grease clearing and acne dispelling
CN102274420A (en) * 2011-08-15 2011-12-14 成都绿迪科技有限公司 Chinese medicine for treating acne composition

Also Published As

Publication number Publication date Type
FR2836377B1 (en) 2005-02-11 grant

Similar Documents

Publication Publication Date Title
Gallagher The effect of antioxidants on poisoning by carbon tetrachloride
Carlsten et al. Arterial concentrations of free fatty acids and free amino acids in healthy human individuals at rest and at different work loads
US4058594A (en) Immuno-suppressive agents
US3993775A (en) Immuno-suppressive agents
US7182956B2 (en) Stable topical drug delivery compositions
US4439432A (en) Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
Visioli et al. Dietary intake of fish vs. formulations leads to higher plasma concentrations of n− 3 fatty acids
Yoshida et al. Effect of total parenteral nutrition, systemic sepsis, and glutamine on gut mucosa in rats
Sallis et al. Calcium metabolism in relation to vitamin D and adrenal function in the chick
Meriggiola et al. An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men
US5472713A (en) Therapeutic uses of emu oil
US5880117A (en) Use of 4-androstenediol to increase testosterone levels in humans
US4927631A (en) Decongestant preparation
US4521411A (en) Analgesic composition
Mahmood et al. Herbal treatment for cardiovascular disease the evidence based therapy.
WO1997003676A1 (en) Novel pharmaceutical formulation of dehydroepiandrosterone for percutaneous topical application
US5145678A (en) Method of reducing blood serum cholesterol
FR2490492A1 (en) Compsns. for treating cellulitis - contg. xanthine base and seaweed extract
US4965075A (en) Methods of increasing 1-series PGs in the body
FR2569347A1 (en) lipid composition growth promoting exoskeleton and cosmetic products containing
EP0087864A2 (en) Pharmaceutical composition
Cave Omega-3 polyunsaturated fatty acids in rodent models of breast cancer
EP0524796A1 (en) Use of essential fatty acids in the preparation of a medicament for the treatment of AIDS
Chalopin et al. Some interrelations between ascorbic acid and adreno-cortical function
Pankhurst et al. An evaluation of techniques for the administration of 17β-extradiol to teleosts

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20061031

RN Application for restoration
FC Favourable decision of inpi director general on an application for restauration.
ST Notification of lapse

Effective date: 20100730